Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$549,263,204
+$28,020,082 QoQ
Shares Held
2,162,709
+1.4% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#92
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AVIVA PLC holds $4,883,087,810 across 10 Drug Manufacturers - General names. JNJ ranks #3 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
10,899,700 | $2,066,801,114 | |
| 2 | LLY |
ELI LILLY & Co
|
718,261 | $861,503,863 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
2,162,709 | $549,263,204 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,264,106 | $419,437,621 | |
| 5 | ABBV |
AbbVie Inc.
|
1,664,656 | $418,894,035 | |
| 6 | AMGN |
Amgen Inc
|
471,664 | $170,798,967 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,183,858 | $149,568,619 | |
| 8 | PFE |
Pfizer Inc
|
4,977,327 | $119,854,034 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $549,263,204 | 2,162,709 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $521,243,122 | 2,132,397 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $429,215,748 | 2,074,007 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $354,419,575 | 1,911,442 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $275,146,283 | 1,801,285 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $279,069,581 | 1,682,764 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $209,834,798 | 1,450,939 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $247,827,499 | 1,529,233 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $218,289,375 | 1,493,496 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $196,107,984 | 1,239,699 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $190,397,250 | 1,214,733 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $171,614,072 | 1,101,856 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $196,585,455 | 1,187,684 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $148,257,500 | 956,500 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $173,926,940 | 984,585 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $134,300,379 | 822,113 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $152,839,127 | 861,017 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $130,833,667 | 738,214 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $146,717,158 | 857,644 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $151,668,041 | 939,121 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $166,432,867 | 1,010,276 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $163,715,278 | 996,138 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $153,322,427 | 974,218 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $143,678,428 | 965,062 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $140,663,749 | 1,000,240 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $136,417,160 | 1,040,320 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||